According to the report, there will be significant developments or changes in the following five areas of the health care industry in the United States in 2019:
Behavioral health epidemic：
Mandatory behavioral health screening and more rational dosing techniques will be added to medical activities; new processes and technologies to find alternatives to opiates and prevent their abuse will be an important trend next year. Currently, more than 130 people in the United States die every day from an opiate-related drug overdose. According to the report, 80 percent of heroin users abuse prescription opioids before using heroin. As a result, the cost of treatment in the United States continues to rise. The cost of treating prescription opioid abuse alone is more than $28.9 billion a year. This highlights the epidemic trend of behavioural health disorders. However, behavioral health problems have been identified and treated from eating disorders, anxiety and depression to suicidal tendencies, but the health care system in the United States has not yet been fully established. It is not possible to assess the mental health status of patients promptly and accurately at all access points providing medical services, so there is a delay of 8 to 10 years from the first symptoms of mental health problems to the beginning of intervention. As a result, health care providers need to better identify and treat behavioural problems before they become real ones.
Precision medical treatment ：
Precision medicine (precision medicine or pharmacogenomics) is expected to become popular outside of oncology by 2019. By comparing patients' tumor DNA with normal cells, precision medicine allows researchers to understand how cancer occurs and find therapeutic targets. By tracking the gene map of the patient's tumor, you can also understand which therapies are most effective for the patient. At present, it has achieved great success in the field of oncology. In addition, pharmacogenomics can provide better treatments by focusing on patients' protein interactions and gene composition. A new study by American biotechnology company Scipher Medicine found that 65 percent of patients who received prescriptions for the world's top five best-selling drugs did not respond to the treatment. This year, Northwestern University conducted a new study, using gene mapping analysis of joint tissue to use accurate medicine for rheumatoid arthritis to determine which drugs are suitable for which patients; Multiple sclerosis researchers are now also able to identify prognostic biomarkers to track and predict individual disease progression and determine which treatment works best. In short, the industry needs both more accurate treatment for patients and new ways to reduce overspending on prescription and drug research, so precision medicine will have an immediate impact.
Outpatient surgical center：
Medical procedures are expected to move faster to outpatient centers and more innovations will be made to make them more professional. Data show that the number of patients treated in outpatient surgery facilities has increased over the past 4-5 years. With the encouragement and authorization of insurance companies, patients have come to understand the benefits of receiving treatment in professional care centres (outpatient surgery centers) in a timely manner, rather than having to be hospitalized. In addition, (ASC) and other outpatient centers are becoming increasingly professional, focusing on better patient care. With the development of minimally invasive vascular surgery in ASC environment, complex surgery is expected to continue to enter the outpatient field. Some studies have shown that ASCs has greater efficacy and lower infection rates, saving millions of lives each year. As a result, we expect innovations to meet the needs of these more specialized centres in 2019.
Health care network security：
Medical institutions are expected to gradually narrow the gap between medical network security standards and other industry standards. The FortiGuard Labs reports that in the past year, healthcare industry groups have been hit by an average of 32000 cyber attacks a day, compared with an average of 14300 for other industry groups. Medical institutions still lag far behind the financial and retail sectors in setting standards for cyber security. While data from financial services agencies or retailers are more useful for cybercriminals, stolen health data can be worth 10 to 20 times more than credit card information on the black market. But 2018 could be the worst year for the healthcare industry in terms of cyber vulnerabilities, with data leaks increasing every quarter, with 4.39 million medical records exposed in the third quarter alone. Although investors in the medical industry are investing in new health care security measures, intrusion methods are becoming more and more complex. Therefore, the application of health care network security will have good growth potential.
Machine learning and ai health care：
Major acquisitions in the artificial intelligence and machine learning sectors are expected to reshape the industry in 2019. The volume of deals and equity financing for healthcare AI startups has grown steadily over the past year, reaching an all-time high in the last quarter, with the healthcare sector becoming the most heavily traded AI industry. Google's DeepMind plans to launch a clinical trial in 2019 to try out a product that can diagnose eye disease through AI; Apple has invested in ResearchKit and CareKit software frameworks that will use machine learning to provide medical researchers with more reliable and meaningful data; BeyondVerbal, another AI start-up, is working on voice models to diagnose chronic diseases over the phone. At present, there are hundreds of new medical artificial intelligence programs are starting. There is no doubt that hundreds more will appear in 2019. Pharmaceutical companies, in particular, will drive this trend by investing in artificial intelligence ahead of time.
While we think these trends are important in 2019, they are in fact the tip of the iceberg. Health care professionals and investors must keep a close eye on these and other trends, as they will evolve over the next year or more, with varying degrees of impact on the industry. As the healthcare industry continues to reform to improve patient care, investors must also understand how to adjust their investment strategies accordingly.
Previous: 2019, EU regulatory reform